技术与方法 |
|
|
|
|
利用CRISPR/Cas9技术构建AEG-1基因敲除U251细胞系并探讨其转移行为的特点 * |
盛玉瑞1,李斌1,王斌1,2,左娣2,马琳2,任晓璠2,郭乐1,3,**(),刘昆梅2,**() |
1 宁夏医科大学临床医学院 银川 750004 2 宁夏医科大学宁夏颅脑疾病重点实验室 银川 750004 3 宁夏临床微生物重点实验室 宁夏医科大学总医院 银川 750003 |
|
The Construction of AEG-1-Knockout U251 Cell Line by CRISPR/Cas9 Technology and Study of The Effect of AEG-1 on the Metastasis in U251 Cells |
Yu-rui SHENG1,Bin LI1,Bin WANG1,2,Di ZUO2,Lin MA2,Xiao-fan REN2,Le GUO1,3,**(),Kun-mei LIU2,**() |
1 Ningxia Medical University Clinical Medical College , Yinchuan 750004, China 2 Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan 750004, China 3 Ningxia Clinical Microbiology Key Laboratory, Yinchuan 750003, China |
引用本文:
盛玉瑞,李斌,王斌,左娣,马琳,任晓璠,郭乐,刘昆梅. 利用CRISPR/Cas9技术构建AEG-1基因敲除U251细胞系并探讨其转移行为的特点 *[J]. 中国生物工程杂志, 2018, 38(10): 38-47.
Yu-rui SHENG,Bin LI,Bin WANG,Di ZUO,Lin MA,Xiao-fan REN,Le GUO,Kun-mei LIU. The Construction of AEG-1-Knockout U251 Cell Line by CRISPR/Cas9 Technology and Study of The Effect of AEG-1 on the Metastasis in U251 Cells. China Biotechnology, 2018, 38(10): 38-47.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20181005
或
https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I10/38
|
[1] |
Yoo B K, Emdad L, Lee S G , et al. Astrocyte elevated gene-1(AEG-1):a multifunctional regulator of normal and abnormal physiology. Pharmacology & Therapeutics, 2011,130(1):1-8.
doi: 10.1016/j.pharmthera.2011.01.008
pmid: 21256156
|
[2] |
Lee S G, Kang D C, Desalle R , et al. AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression. Adv Cancer Res, 2013,120:1-38.
doi: 10.1016/B978-0-12-401676-7.00001-2
|
[3] |
Ash S C, Yang D Q, Britt D E . LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochemical & Biophysical Research Communications, 2008,371(2):333-338.
doi: 10.1016/j.bbrc.2008.04.084
pmid: 2573900
|
[4] |
Emdad L, Lee S G, Su Z Z , et al. Astrocyte elevated gene-1(AEG-1) functions as an oncogene and regulates angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 2009,106(50):21300-21305.
doi: 10.1073/pnas.0910936106
|
[5] |
Kang D C, Su Z Z, Sarkar D , et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene, 2005,353(1):8-15.
doi: 10.1016/j.gene.2005.04.006
pmid: 15927426
|
[6] |
Yoo B K, Chen D, Su Z Z , et al. Molecular mechanism of chemoresistance by astrocyte elevated Gene-1. Cancer Research, 2010,70(8):3249-3258.
doi: 10.1158/0008-5472.CAN-09-4009
pmid: 2855753
|
[7] |
Emdad L, Sarkar D, Lee S G , et al. Astrocyte elevated gene-1:a novel target for human glioma. Molecular Cancer Therapeutics, 2010,9(1):79-88.
doi: 10.1158/1535-7163.MCT-09-0752
pmid: 20053777
|
[8] |
Sander J D, Joung J K . CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol, 2014,32(4):347-355.
doi: 10.1038/nbt.2842
pmid: 24584096
|
[9] |
Pelletier S, Gingras S, Green D R . Mouse genome engineering via CRISPR-Cas9 for study of immune function. Immunity, 2015,42(1):18-27.
doi: 10.1016/j.immuni.2015.01.004
pmid: 4720985
|
[10] |
Liu L, Wu J, Ying Z , et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Research, 2010,70(9):3750-3759.
doi: 10.1158/0008-5472.CAN-09-3838
|
[11] |
Ota S, Kawahara A . Zebrafish: a model vertebrate suitable for the analysis of human genetic disorders. Congenit Anom, 2014,54(1):8-11.
doi: 10.1111/cga.12040
pmid: 24279334
|
[12] |
Xue W, Chen S D, Yin H , et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature, 2014,514(7522):380-384.
doi: 10.1038/nature13589
pmid: 25119044
|
[13] |
Su S, Hu B, Shao J , et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep, 2016,6:20070.
doi: 10.1038/srep20070
pmid: 4730182
|
[14] |
Ren J, Zhang X, Liu X , et al. A versatile system for rapid multiplex genome-edited CAR T cell generation. Oncotarget, 2017,8(10):17002-17011.
doi: 10.18632/oncotarget.15218
pmid: 28199983
|
[15] |
Merhavi-Shoham E, Itzhaki O, Markel G , et al. Adoptive cell therapy for metastatic melanoma. Cancer J, 2017,23(1):48-53.
doi: 10.1097/PPO.0000000000000240
pmid: 28114254
|
[16] |
Shao H, Lin Y, Wang T , et al. Identification of peptide-specific TCR genes by in vitro peptide stimulation and CDR 3 length polymorphism analysis. Cancer Lett, 2015,363(1):83-91.
doi: 10.1016/j.canlet.2015.04.001
pmid: 25890221
|
[17] |
邵红伟, 陈辉, 彭鑫 , 等. CRISPR-Cas9系统定向编辑TCR基因的sgRNA筛选. 集美大学学报(自然版), 2015,20(4):265-270.
doi: 10.3969/j.issn.1007-7405.2015.04.005
|
|
Shao H W, Chen H, Peng X , et al. SgRNA screening of directed edited TCR gene in CRISPR-Cas9 system. Journal of Jimei University (Natural Science), 2015,20(4):265-270.
doi: 10.3969/j.issn.1007-7405.2015.04.005
|
[18] |
Ren J, Liu X, Fang C , et al. Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin Cancer Res, 2016,23(9):2255-2266.
|
[19] |
Steinhart Z, Pavlovic Z, Chandrashekhar M , et al. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors. Nat Med, 2017,23(1):60-68.
doi: 10.1038/nm.4219
pmid: 27869803
|
[20] |
Cheong T C, Compagno M, Chiarle R . Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system. Nat Commun, 2016,7:10934.
doi: 10.1038/ncomms10934
pmid: 26956543
|
[21] |
Cong L, Ran F A, Cox D , et al. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013,339(6121):819-823.
doi: 10.1126/science.1231143
|
[22] |
Jinek M, Jiang F, Taylor D W , et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science, 2014,343(6176):1247997.
doi: 10.1126/science.1247997
|
[23] |
Liu L, Fan X D . CRISPR-Cas system: a powerful tool for genome engineering. Plant Mol Biol, 2014,85(3):209-218.
doi: 10.1007/s11103-014-0188-7
pmid: 24639266
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|